Factors Associated with Depression in COPD: A Multicenter Study

Lung

Volumn 194, Issue 3, 2016, Pages 335-343

  Martinez Rivera, Carlos ^a   Costan Galicia, Joaquín ^b   Alcázar Navarrete, Bernardino ^c   Garcia Polo, Cayo ^d   Ruiz Iturriaga, Luis Alberto ^e   Herrejón, Alberto ^f   Ros Lucas, Jose Antonio ^g   García Sidro, Patricia ^h   Tirado Conde, Gema ⁱ   López Campos, Jose Luis ^j   Mayoralas Alises, Sagrario ^k   de Miguel Díez, Javier ^l   Esquinas, Cristina ^m   Miravitlles, Marc ^m  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b Lozano Blesa Hospital   (Spain)

^c Respiratory Department   (Spain)

^d HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

^e HOSPITAL DE CRUCES   (Spain)

^f Hospital Dr Pesset   (Spain)

^g HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^h HOSPITAL DE LA PLANA   (Spain)

ⁱ HOSPITAL UNIVERSITARIO DE PUERTO REAL   (Spain)

^j HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^k HOSPITAL RAMÓN Y CAJAL   (Spain)

^l HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^m HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

more..

Author keywords

COPD; Depression; HAD; Quality of life

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; INFLUENZA VACCINE; IPRATROPIUM BROMIDE; MUCOLYTIC AGENT; OXYGEN; THEOPHYLLINE; TIOTROPIUM BROMIDE;

ADULT; AGE; AGED; AIRWAY OBSTRUCTION; ARTICLE; BODY MASS; CHARLSON COMORBIDITY INDEX; CHRONIC OBSTRUCTIVE LUNG DISEASE; CROSS-SECTIONAL STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE EXACERBATION; DYSPNEA; EMERGENCY WARD; EXERCISE TEST; FEMALE; FORCED EXPIRATORY VOLUME; HEART FAILURE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; OXYGEN THERAPY; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; WALKING SPEED; CASE CONTROL STUDY; CLINICAL TRIAL; COMPLICATION; EXERCISE TOLERANCE; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGY; RECURRENT DISEASE; RISK FACTOR; WALK TEST;

AGED; BODY MASS INDEX; CASE-CONTROL STUDIES; DEPRESSION; DYSPNEA; EXERCISE TOLERANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RISK FACTORS; SURVEYS AND QUESTIONNAIRES; SYMPTOM FLARE UP; WALK TEST;

EID: 84959342229     PISSN: 03412040     EISSN: 14321750     Source Type: Journal    
DOI: 10.1007/s00408-016-9862-7     Document Type: Article

References (49)

1. Mathers CD, Loncar D (2006) Projections of global mortality and burden of disease from 2002 to 2030. Plos Med 3:e442
2. Miravitlles M, Soriano JB, García-Río F et al (2009) Prevalence of COPD in Spain: Impact of undiagnosed COPD on quality of life and daily life activities. Thorax 64:863–868
3. Nishimura K, Izumi T, Tsukino M, Oga T (2002) on behalf of the Kansai COPD Registry and Research Group in Japan. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 121(5):1434–1440
4. Garcia-Aymerich J, Lange P, Benet M et al (2006) Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 61:772–778
5. Celli BR, Cote CG, Marín JM et al (2004) The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350:1005–1012
6. Miravitlles M, Price D, Rabe K, Schmidt H, Metzdorf N, Celli B (2015) Comorbidities of patients in tiotropium clinical trials: comparison with observational studies of patients with chronic obstructive pulmonary disease. Int J ChronObstPulm Dis 10:549–564
7. Haro JM, Palacín C, Vilagut G et al (2006) Prevalencia de los trastornos mentales y factores asociados: resultados del estudio ESEMeD-España. Med Clin (Barc) 126:445–451
8. Al-Shair K, Dockry R, Mallia-Milanes B et al (2009) Depression and its relatihonship with poor exercise capacity, BODE index and muscle wasting in COPD. Respir Med 102:1572–1579
9. Schane RE, Woodruff PG, Dinno A et al (2008) Prevalence and risk factors for depressive symptoms in persons with chronic obstructive pulmonary disease. J Gen Intern Med 23(11):1757e62
10. Ng TP, Niti M, Tan WC et al (2007) Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med 167(1):60e7
11. van Manen JG, Bindels PJE, Dekker FW et al (2002) Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax 57:412–416
12. Yohannes AM, Roomi J, Baldwin RC, Connolly MJ (1998) Depression in elderly outpatients with disabling chronic obstructive pulmonary disease. Age Ageing 27:155e60
13. Kim KU, Park HK, Jung HY et al (2014) Association of depression with disease severity in patients with chronic obstructive pulmonary disease. Lung 192:243–249
14. Hanania N, Müllerova H, Locantore W, Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Study Investigators et al (2011) Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med 183:604–611
15. Miravitlles M, Molina J, Quintano JA, Campuzano A, Pérez J, Roncero C (2014) Factors associated with depression and severe depression in patients with COPD. Respir Med 108:1615–1625
16. Jordan N, Lee TA, Valenstein M, Weiss KB (2007) Effect of care setting on evidence-based depression treatment for veterans with COPD and comorbid depression. J Gen Intern Med 22:1447–1452
17. Xu W, Collet JP, Shapiro S et al (2008) Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am J Respir Crit Care Med 178:913–920
18. Quint JK, Baghai-Ravary R, Donaldson GC, Wedzicha JA (2008) Relationship between depression and exacerbations in COPD. Eur Respir J 32:53–60
19. Dahlen I, Janson C (2002) Anxiety and depression are related to the outcome of emergency treatment in patients with obstructive pulmonary disease. Chest 122:1633–1637
20. Stage KB, Middelboe T, Pisinger C (2005) Depression and chronic obstructive pulmonary disease (COPD). Impact on survival. Acta Psychiatr Scand 111:320–323
21. Dalal A, Shah M, Lunacsek O, Hanania NA (2011) Clinical and economic burden of depression/anxiety in chronic obstructive pulmonary disease patients within a managed care population. COPD 8(4):293–299
22. Alcázar B, García-Polo C, Herrejon A et al (2012) Factors associated with hospital admission for exacerbation of chronic obstructive pulmonary disease. Arch Bronconeumol 48(3):70–76
23. García-Polo C, Alcázar-Navarrete B, Ruiz-Iturriaga LA, Herrejón A, Ros-Lucas JA, García-Sidro P et al (2012) Factors associated with high resource utilisation among COPD patients. Respir Med 106:1734–1742
24. Herrero MJ, Blanch J, Peri JM et al (2003) A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population. Gen Hosp Psychiatry 25:277–283
25. Bestall JC, Paul EA, Garrod R et al (1999) Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability inpatients with chronic obstructive pulmonary disease. Thorax 54:581–586
26. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383
27. Badia X, Roset M, Monserrat S et al (1999) La versión española del EuroQoL: descripción y aplicaciones. Med Clin (Barc) 112:79–86
28. Vilaró J, Gimeno E, Sánchez Férez N et al (2007) Actividades de la vida diaria en pacientes con enfermedad pulmonar obstructiva crónica: validación de la traducción española y análisis comparativo de 2 cuestionarios. Med Clin (Barc) 29:326–332
29. Miravitlles M, Soler-Cataluña JJ, Calle M, Molina J, Almagro P, Quintano JA et al (2014) Spanish guideline for COPD (GesEPOC). Update 2014. Arch Bronconeumol 50(Suppl 1):1–16
30. Iguchi A, Senjyu H, Hayashi Y et al (2013) Relationhip between depression in patients with COPD and the percent of predicted FEV1, BODE Index, and Health-Related Quality of Life. Respir Care 58(2):334–339
31. Cleland JA, Lee AJ, Hall S (2007) Associations of depression and anxiety with gender, age, health-related quality of life and symptoms in primary care COPD patients. Fam Pract 24:217–223
32. Gudmundsson G, GislasonTh Janson Ch et al (2006) Depression, anxiety and health status after hospitalization for COPD: a multicentre study in the Nordic countries. Respir Med 100:87–93
33. Mishima M, Oku Y, Muro Sh et al (1996) Relationship between dyspnea in daily life and psycho-physiologic state in patients with chronic obstructive pulmonary disease during long-term domiciliary oxygen therapy. Intern Med 35:453–458
34. Pooler A, Beech R (2014) Examining the relationship between anxiety and depression and exacerbations of COPD which result in hospital admission: a systematic review. Int J Chron Obst Pulm Dis 9:315–330
35. Di Marco F, Terraneo S, Roggi MA et al (2014) Physical actvity impairment in depressed COPD subjects. Respir Care 59:726–734
36. Miravitlles M, Cantoni J, Naberan K (2014) Factors associated with a low level of physical activity in patients with chronic obstructive pulmonary disease. Lung 192(2):259–265
37. Lou P, Zhu Y, Chen P et al (2012) Prevalence and correlations with depression, anxiety, and other feratures in outpatients with chronic obstructive pulmonary disease in China: a cross-sectional case control study. BMC Pulm Med 12:53
38. Funk GC, Kirchheiner K, Bughuber OC et al (2009) BODE index versus GOLD classification for explaining anxious and depressive symptoms in patients with COPD—a cross-sectional study. Respir Res 10:1
39. Tetikkurt C, Ozdemir I, Tetikkurt S, Yilmaz N et al (2011) Anxiety and depression in COPD patients and correlation with sputum and BAL cytology. Multdiscip Respir Med 6(4):226–231
40. Balcells E, Gea J, Ferrer J et al (2010) Factors affecting the relationship between psychological status and quality of life in COPD patients. Health Qual Life Outcomes 8:108
41. Lacasse Y, Rousseau L, Maltais F (2001) Prevalence of depressive symptoms and depression in patients with severe oxygen-dependent chronic obstructive pulmonary disease. J Cardiopulm Rehabil 21(2):80–86
42. Hajiro T, Nishimura K, Tsukino M et al (2000) Stages of disease severity and factors that affect the health status of patients with chronic obstructive pulmonary disease. Respir Med 94(9):841–846
43. Di Marco F, Verga M, Reggente M et al (2006) Anxiety and depression in COPD patients: the roles of gender and disease severity. Respir Med 100:1767–1774
44. Paz-Diaz H, Montes de Oca M, Lopez JM, Celli BR (2007) Pulmonary rehabilitation improves depression, anxiety, dyspnea and health status in patients with COPD. Am J Phys Med Rehabil 86:30–36
45. Kozora E, Tran ZV, Make B (2002) Neurobehavioral improvement after brief rehabilitation in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil 22:426–430
46. Eiser N, Harte R, Spiros K et al (2005) Effect of treating depression on quality-of-life and exercise tolerance in severe COPD. COPD 2:233–241
47. Borson S, McDonald GJ, Gayle T et al (1992) Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease. Psychosomatics 33:190–201
48. Maurer J, Rebbapragada V, Borson S et al (2008) ACCP Workshop Panel on Anxiety and Depression in COPD. Anxiety and depression in COPD: current understanding, unanswered questions, and research areas. Chest 134(Suppl 4):43S–56S
49. Anderson IM, Nutt DJ, Deakin JF (2000) Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. British Association for Psychopharmacology. J Psychopharmacol 14(1):3–20